Patients believe using marijuana helps them with their symptoms, but the study’s results could indicate the opposite is true for those in addiction treatment.
Formed by Sachin Barot and Denis Chen, the CERESLabs mission is to become the global leader in analytical cannabis product testing.
About 1 in 7 adult primary care patients visiting medical offices reported having used marijuana at least once in the past year.
The partnership will utilize Steep Hill's expertise in analytical testing to customize Eybna's production of terpene formulations for optimizing the medical benefits of cannabis.
Third party lab testing isn’t currently required by Health Canada, but the agency has already required ‘expanded’ testing for licensed producers to ensure that pesticide and additive requirements are being met.
Analyzing the complex chemistry of the cannabis plant may help scientists to develop specific cannabis-based drugs for specific conditions.